BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 15224658)

  • 1. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system.
    Petrucelli L; Dawson TM
    Ann Med; 2004; 36(4):315-20. PubMed ID: 15224658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses.
    Moore DJ; Dawson VL; Dawson TM
    Neuromolecular Med; 2003; 4(1-2):95-108. PubMed ID: 14528055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg.
    Ciechanover A; Brundin P
    Neuron; 2003 Oct; 40(2):427-46. PubMed ID: 14556719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring the ubiquitin/proteasome system in conformational diseases.
    Lindsten K; Dantuma NP
    Ageing Res Rev; 2003 Oct; 2(4):433-49. PubMed ID: 14522245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders.
    Chung KK; Dawson VL; Dawson TM
    Trends Neurosci; 2001 Nov; 24(11 Suppl):S7-14. PubMed ID: 11881748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
    Mattson MP
    Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms.
    Forloni G; Terreni L; Bertani I; Fogliarino S; Invernizzi R; Assini A; Ribizzi G; Negro A; Calabrese E; Volonté MA; Mariani C; Franceschi M; Tabaton M; Bertoli A
    Neurobiol Aging; 2002; 23(5):957-76. PubMed ID: 12392798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin proteasome system in synaptic and axonal degeneration: a new twist to an old cycle.
    Korhonen L; Lindholm D
    J Cell Biol; 2004 Apr; 165(1):27-30. PubMed ID: 15067020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.
    Li Z; Arnaud L; Rockwell P; Figueiredo-Pereira ME
    J Neurochem; 2004 Jul; 90(1):19-28. PubMed ID: 15198663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
    Mariani E; Polidori MC; Cherubini A; Mecocci P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodegeneration: linking ubiquitin/proteasome pathway impairment with inflammation.
    Li Z; Jansen M; Pierre SR; Figueiredo-Pereira ME
    Int J Biochem Cell Biol; 2003 May; 35(5):547-52. PubMed ID: 12672447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders.
    Gong B; Leznik E
    Drug News Perspect; 2007; 20(6):365-70. PubMed ID: 17925890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin biology in neurodegenerative disorders: From impairment to therapeutic strategies.
    Kumar D; Ambasta RK; Kumar P
    Ageing Res Rev; 2020 Aug; 61():101078. PubMed ID: 32407951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transgenic mouse model of the ubiquitin/proteasome system.
    Lindsten K; Menéndez-Benito V; Masucci MG; Dantuma NP
    Nat Biotechnol; 2003 Aug; 21(8):897-902. PubMed ID: 12872133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha synuclein in neurodegenerative disorders: murderer or accomplice?
    Mezey E; Dehejia A; Harta G; Papp MI; Polymeropoulos MH; Brownstein MJ
    Nat Med; 1998 Jul; 4(7):755-7. PubMed ID: 9662355
    [No Abstract]   [Full Text] [Related]  

  • 18. [The ubiquitin-proteasome system and neurodegenerative disease].
    Tanaka K
    No To Shinkei; 2001 Oct; 53(10):935-42. PubMed ID: 11725503
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurological disease: UPS stops delivering!
    Miller RJ; Wilson SM
    Trends Pharmacol Sci; 2003 Jan; 24(1):18-23. PubMed ID: 12498726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.